Late effects of treatment for early-stage Hodgkin's disease
1998

Late Effects of Treatment for Early-Stage Hodgkin's Disease

Sample size: 611 publication Evidence: moderate

Author Information

Author(s): JD Brierley, AJ Rathmell, MK Gospodarowicz, SB Sutcliffe, A Munro, R Tsang, M Pintilie

Primary Institution: University of Toronto, Department of Radiation Oncology

Hypothesis

What are the late effects of treatment for early-stage Hodgkin's disease?

Conclusion

Patients treated for early-stage Hodgkin's disease experience significant late effects, including increased risks of second malignancies and heart disease.

Supporting Evidence

  • Twenty patients died of second malignancy, 14 of heart disease, and nine from respiratory disease.
  • The 15-year incidence of heart disease was 11%.
  • 37 cases of second malignancy were reported with a relative risk of 2.2.
  • 56 men fathered 112 pregnancies, and 40.3% of women became pregnant post-treatment.

Takeaway

This study looked at how people felt after being treated for Hodgkin's disease a long time ago, finding that many had health problems later on.

Methodology

Patients treated for early-stage Hodgkin's disease were surveyed about their health and quality of life after treatment.

Potential Biases

Potential bias due to self-reporting and loss to follow-up.

Limitations

The study is limited by its retrospective nature and the reliance on self-reported data.

Participant Demographics

The study included 611 patients (332 men, 279 women) with a median age of 31 years at diagnosis.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI 1.57-3.08

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication